Methylenetetrahydrofolate reductase (MTHFR) DNA mutation analysis detects common single nucleotide polymorphisms (SNPs) in the MTHFR gene, most notably C677T (rs1801133) and A1298C (rs1801131), which can reduce enzymatic activity and impair folate metabolism. This test is performed on genomic DNA and reports genotype (homozygous, heterozygous, or wild-type) for each variant. Results are interpreted in the context of clinical presentation, homocysteine levels, and folate status rather than in isolation. The MTHFR enzyme catalyzes the irreversible conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the primary circulating form of folate and the methyl donor required for remethylation of homocysteine to methionine. Reduced MTHFR activity—particularly in the thermolabile C677T homozygous variant—can lead to elevated plasma homocysteine (hyperhomocysteinemia) and altered DNA methylation capacity, especially under conditions of low folate intake. The A1298C variant has a more modest effect on enzyme activity and is generally considered clinically significant primarily when compound heterozygous with C677T.
The MTHFR gene provides instructions for making an enzyme that helps your body process folate (a B vitamin) and regulate a substance called homocysteine. Certain common gene variants—especially the C677T variant when inherited from both parents—can reduce how well this enzyme works, sometimes leading to mildly elevated homocysteine levels. Most people with these variants have no symptoms and can maintain healthy homocysteine levels by eating a balanced diet rich in folate, B12, and B6, or by taking standard folic acid supplements. Having an MTHFR variant does not mean you have a disease, and most major medical organizations do not recommend routine testing because the results rarely change medical management. If your doctor ordered this test, they will interpret it alongside other lab results and your personal health history.
When elevated: Homozygous C677T (TT) genotype is associated with moderately elevated homocysteine levels, particularly when folate status is suboptimal. Compound heterozygosity (C677T + A1298C) may also result in reduced enzyme activity and mild hyperhomocysteinemia. Elevated homocysteine—regardless of MTHFR genotype—is an independent risk marker for cardiovascular disease, venous thromboembolism, and adverse pregnancy outcomes, though causality remains debated. In the context of neural tube defect risk, C677T homozygosity in the mother is associated with modestly increased risk, supporting adequate periconceptional folate supplementation. When low: This is a genetic test reporting variant status (not a quantitative result), so 'low' results correspond to wild-type or heterozygous genotypes with normal or near-normal enzyme activity. Wild-type (CC for C677T; AA for A1298C) individuals have no genetically mediated reduction in MTHFR enzyme activity from these variants. A normal MTHFR genotype does not exclude other causes of hyperhomocysteinemia, such as B12 or B6 deficiency, renal insufficiency, or other genetic variants.
MTHFR variants may influence methylation capacity and homocysteine metabolism, which some research links to cardiovascular health and recovery—relevant for endurance athletes. However, variants alone don't predict performance or injury risk; functional status depends on folate intake, B12, and measured homocysteine levels, making this primarily a genetic susceptibility marker rather than a direct athletic performance tool.
Turnaround Time
3 days (up to 7 days)
Fasting Required
No
Order online
Choose your lab and check out. We send your lab requisition automatically — no doctor visit needed.
Get your sample collected
Visit a lab service center near you for a quick blood draw (or book at-home phlebotomy where available).
See your results
Your results land in your Insider portal, ready to review and act on — that easy.
Your price
$127.00$230
1.8× less than retail
Versus the typical direct-to-consumer retail price for this test (illustrative — consumer prices vary by provider and region).
$127.00
$190.00
Peer-reviewed sources supporting the educational content on this page.
